Search Results - "Nichol, Geoff"
-
1
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
Published in Journal of clinical oncology (20-12-2008)“…The primary objective of this phase I/II study was to determine the safety and pharmacokinetic profile of either transfectoma- or a hybridoma-derived…”
Get full text
Journal Article -
2
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
Published in Journal of clinical oncology (01-09-2005)“…Previously, we reported our experience treating 14 patients with metastatic melanoma using a fully human antibody to cytotoxic T-lymphocyte antigen-4…”
Get full text
Journal Article -
3
ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates
Published in Blood (03-12-2015)“…Hemophilia is an attractive target for gene therapy, since activity levels as low as 1% to 2% of normal are beneficial and levels of ~5% prevent spontaneous…”
Get full text
Journal Article -
4
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Published in The New England journal of medicine (06-03-2014)“…In this small study, investigators genetically disrupted the HIV receptor CCR5 in CD4 T cells of aviremic persons who were infected with HIV. After reinfusion…”
Get full text
Journal Article -
5
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2012)“…Objective CXCL10 (also known as interferon‐γ–inducible 10‐kd protein [IP‐10]) is a chemokine that potentially plays a role in the immunopathogenesis of…”
Get full text
Journal Article -
6
Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma
Published in Clinical cancer research (15-02-2011)“…To determine safety and feasibility of adjuvant ipilimumab following resection of high-risk melanoma and to identify surrogate markers for benefit. In this…”
Get full text
Journal Article -
7
-
8
684. Enhanced FVIII AAV Vector Cassette Produces Improved Virus Yields and Supraphysiological FVIII Levels In Vivo
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
9
Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy
Published in Blood (02-12-2016)“…Hemophilia A, which is caused by a mutation in the Factor 8 (F8) gene resulting in a deficiency or lack of the Factor VIII (FVIII) protein, is the most common…”
Get full text
Journal Article -
10
Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man
Published in Journal of allergy and clinical immunology (01-04-1990)“…We studied the effects of prostacyclin (PGI2) on the airway responses to platelet-activating factor (PAF) in a randomized and crossover study in eight normal…”
Get more information
Journal Article -
11
Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin
Published in The American review of respiratory disease (01-07-1990)“…Inhaled furosemide prevents bronchoconstriction induced by nebulized distilled water, exercise, and antigen challenge. We examined the effect of furosemide on…”
Get more information
Journal Article